Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medical Error Mandatory Reporting System Recommended By IoM

Executive Summary

A mandatory reporting system for medical errors and adverse events that result in death or serious harm should be required by Congress, the Institute of Medicine recommended in a report released Nov. 29.

You may also be interested in...



HHS "Partnership For Patients" Plan Includes Goal Of Halving Preventable Drug Adverse Events In Hospitals

New initiative's targets also include reducing preventable hospital-acquired conditions 40% by the end of 2013.

FDA Safety Cmte. Consumer Rep Levin Is Critic Of Speedy Drug Reviews

FDA's Drug Safety & Risk Management Advisory Committee consumer representative Arthur Levin will likely urge closer scrutiny of the safety profile of non-breakthrough drugs during NDA reviews

FDA Safety Cmte. Consumer Rep Levin Is Critic Of Speedy Drug Reviews

FDA's Drug Safety & Risk Management Advisory Committee consumer representative Arthur Levin will likely urge closer scrutiny of the safety profile of non-breakthrough drugs during NDA reviews

Related Content

UsernamePublicRestriction

Register

LL1126093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel